Accéder à l'en-tête
Accéder au contenu principal
Accéder au pied de page
Group
About us
Our locations
Sustainability
Expertise
Therapeutic areas
M&A / In-Licencing
Life cycle management
Portfolio
News
Partnership
Your career at LXO
Contact us
EN
FR
Latest company
news
Check out all the articles published by LXO Group to stay updated on our news and learn more about our various projects. Together, let’s move towards a healthier future!
All news
Expertises
Geographical areas
Female Success: A Plural Definition and a Path to Autonomy
At Laboratoire XO, we celebrated Women’s Rights Day by redefining success: unique to each woman, rooted in autonomy, and built on inclusivity.
17.03.25
LXO Group publishes its latest ESG report
LXO Group is proud to announce the publication of its latest ESG report. The report details the company’s efforts and achievements over the past year in terms of sustainability, ethics and social commitment.
04.09.24
LXO Group announces the acquisition of prescription drug Nimotop® from Bayer
Press Release, november 06th, 2023 – Laboratoire X.O (“LXO”), is pleased to announce the acquisition of prescription drug Nimodipine under the brand name Nimotop® from Bayer, for several markets across different regions.
06.11.23
LXO Group moves into a new phase of growth with the support of Stanley Capital
Press Release, october 04th, 2022 – Stanley Capital Partners (SCP) has acquired a majority stake in French pharmaceutical group Laboratoire XO (Lab XO). Debt was provided by US giant Ares Management.
04.10.22
